3McNicholas MM, Mercer PM, Miller JC, et al. Color Doppler sonography in the evaluation of palpable breast masses[J]. AJR, 1993, 161 (4): 765.
4周永吕,郭万学.超声医学[M].4版.北京:科学技术文献出版社.2002:402-405.
5Smith IC,Heys SD,Hutcheon AW,et al.Neoadjuvant chemotherapy in breast cancer:significantly enhanced response with docetaxel.J Clin Oncol,2002,20(6):1456-1466.
6Fishher ER,Wang J,Bryant J,et al.Pathobiology of preoperative chemotherapy:findings form the National Surgical Adjuvant Breast and Bowel(NSABP)B-18.Cancer,2002,95(4):681-695.
7Kaufmann M,Hortobagyi GN,Goldhimch A.et al.Recommendations from an international expert panel on the used neoadjuvant (primary) systemic treatment of operable breast cancer:an update.J Clin Oncol,2006,24(12):1940-1949.
8Shimizu C,Ando M,Kouno T,et al.Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer,JPN J Clin Oncol,2007,37(1):1-8.
9Berry DA,Cirrincione C,Henderson IC,et al.Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.JAMA,2006,295(14):1658-1667.
10Faneyte IF,Sehrama JG,Peterse JL,et al.Breast cancer response to neoadjuvant chemotherapy:predictive markers and relation with outcome.Br J Cancer,2003,88:406.
